ABC transporters as molecular effectors of pancreatic oncogenic pathways: the Hedgehog-GLI model (Q37718060)

22 August 2017

1 reference

title

ABC transporters as molecular effectors of pancreatic oncogenic pathways: the Hedgehog-GLI model (English)

1 reference

22 August 2017

1

Marta Santisteban

1 reference

22 August 2017

1 September 2010

1 reference

Journal of gastrointestinal cancer

22 August 2017

1 reference

22 August 2017

41

1 reference

22 August 2017

3

1 reference

22 August 2017

153-158

1 reference

https://scigraph.springernature.com/pub.10.1007/s12029-010-9144-1

22 August 2017

0 references

cites work

Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview.

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9144-1

Redox regulation of multidrug resistance in cancer chemotherapy: molecular mechanisms and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9144-1

The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9144-1

Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9144-1

ABC multidrug transporters: structure, function and role in chemoresistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9144-1

Tumour stem cells and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9144-1

Pancreatic cancer stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9144-1

Pancreatic cancer stem cells: implications for the treatment of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9144-1

Induction of human MDR1 gene expression by 2-acetylaminofluorene is mediated by effectors of the phosphoinositide 3-kinase pathway that activate NF-kappaB signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9144-1

LY294,002, a specific inhibitor of PI3K/Akt kinase pathway, antagonizes P-glycoprotein-mediated multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9144-1

Oral mTOR inhibitor everolimus in patients with gemcitabine-refractory metastatic pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9144-1

Maintenance of retinal stem cells by Abcg2 is regulated by notch signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9144-1

Transcriptional regulation of ABC drug transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9144-1

GLI1 is regulated through Smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates PDAC cell survival and transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9144-1

Primers on molecular pathways GLI: more than just Hedgehog?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9144-1

Cancer stem cells: redefining the paradigm of cancer treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9144-1

21 January 2018

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9144-1

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9144-1

Targeting the hedgehog pathway to mitigate treatment resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9144-1

Hedgehog: an attribute to tumor regrowth after chemoradiotherapy and a target to improve radiation response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9144-1

Sonic Hedgehog promotes multiple drug resistance by regulation of drug transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9144-1

Targeted therapy for cancer stem cells: the patched pathway and ABC transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9144-1

The hedgehog pathway as a therapeutic target for treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9144-1

Cancer-associated stromal fibroblasts promote pancreatic tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9144-1

Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9144-1

Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9144-1

Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9144-1

A paracrine requirement for hedgehog signalling in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9144-1

Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9144-1

Sonic hedgehog acts at multiple stages during pancreatic tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9144-1

Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9144-1

Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9144-1

Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9144-1

The absence of human equilibrative nucleoside transporter 1 is associated with reduced survival in patients with gemcitabine-treated pancreas adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9144-1

Meta-Analyses of Chemotherapy for Locally Advanced and Metastatic Pancreatic Cancer

21 January 2018

1 reference

12 December 2020

Combined targeted treatment to eliminate tumorigenic cancer stem cells in human pancreatic cancer.

1 reference

12 December 2020

Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C.

1 reference

12 December 2020

Activation of beta-catenin signalling by GSK-3 inhibition increases p-glycoprotein expression in brain endothelial cells

1 reference

12 December 2020

Context, tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvironment?

1 reference

12 December 2020

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

1 reference

12 December 2020

10.1007/S12029-010-9144-1

Identifiers

DOI

1 reference

release_ud3voyibizchfkrutueutmkaie

22 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ud3voyibizchfkrutueutmkaie

24 November 2022

mapped directly with Wikidata item

PubMed ID

20333482

1 reference

PubMed ID

20333482